CN102653554A - 功能性结核分枝杆菌抗原多肽及其应用 - Google Patents
功能性结核分枝杆菌抗原多肽及其应用 Download PDFInfo
- Publication number
- CN102653554A CN102653554A CN2012101150863A CN201210115086A CN102653554A CN 102653554 A CN102653554 A CN 102653554A CN 2012101150863 A CN2012101150863 A CN 2012101150863A CN 201210115086 A CN201210115086 A CN 201210115086A CN 102653554 A CN102653554 A CN 102653554A
- Authority
- CN
- China
- Prior art keywords
- polypeptide
- mouse
- application
- sequence
- pep1
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title claims abstract description 26
- 229920001184 polypeptide Polymers 0.000 title claims abstract description 24
- 102000004196 processed proteins & peptides Human genes 0.000 title claims abstract description 24
- 239000000427 antigen Substances 0.000 title abstract description 15
- 102000036639 antigens Human genes 0.000 title abstract description 15
- 108091007433 antigens Proteins 0.000 title abstract description 15
- 241000187479 Mycobacterium tuberculosis Species 0.000 title abstract description 11
- 210000004698 lymphocyte Anatomy 0.000 claims abstract description 19
- 229960005486 vaccine Drugs 0.000 claims abstract description 10
- 201000008827 tuberculosis Diseases 0.000 claims abstract description 9
- 125000003275 alpha amino acid group Chemical group 0.000 claims abstract description 7
- 210000000952 spleen Anatomy 0.000 claims description 17
- 210000004027 cell Anatomy 0.000 claims description 13
- 208000015181 infectious disease Diseases 0.000 claims description 10
- 238000002360 preparation method Methods 0.000 claims description 5
- 241000894006 Bacteria Species 0.000 claims description 4
- 239000003795 chemical substances by application Substances 0.000 claims description 4
- 230000008521 reorganization Effects 0.000 claims description 2
- 230000009261 transgenic effect Effects 0.000 claims description 2
- 239000013598 vector Substances 0.000 claims description 2
- 241000894007 species Species 0.000 claims 1
- 238000006243 chemical reaction Methods 0.000 abstract description 6
- 241000699670 Mus sp. Species 0.000 abstract description 4
- 210000004989 spleen cell Anatomy 0.000 abstract description 2
- 210000002966 serum Anatomy 0.000 abstract 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 34
- 108010088535 Pep-1 peptide Proteins 0.000 description 24
- CQTGBCFGAAYOCY-ZCRNMIQFSA-N (3S)-3-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-acetamido-3-methylbutanoyl]amino]-3-methylbutanoyl]amino]-3-phenylpropanoyl]amino]-3-hydroxybutanoyl]amino]-3-hydroxypropanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-5-amino-5-oxopentanoyl]amino]-4-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-amino-3-methyl-1-oxobutan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-4-oxobutanoic acid Chemical compound CC(C)C[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@@H](NC(C)=O)C(C)C)C(C)C)[C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C(C)C)C(N)=O CQTGBCFGAAYOCY-ZCRNMIQFSA-N 0.000 description 20
- 101100189913 Caenorhabditis elegans pept-1 gene Proteins 0.000 description 20
- 239000000243 solution Substances 0.000 description 13
- 238000002474 experimental method Methods 0.000 description 11
- 210000002751 lymph Anatomy 0.000 description 9
- 239000012980 RPMI-1640 medium Substances 0.000 description 7
- 235000015097 nutrients Nutrition 0.000 description 7
- 210000001519 tissue Anatomy 0.000 description 7
- 230000000527 lymphocytic effect Effects 0.000 description 6
- 238000011160 research Methods 0.000 description 6
- 230000000694 effects Effects 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 230000002265 prevention Effects 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 3
- 210000001165 lymph node Anatomy 0.000 description 3
- 230000035755 proliferation Effects 0.000 description 3
- 102000005431 Molecular Chaperones Human genes 0.000 description 2
- 108010006519 Molecular Chaperones Proteins 0.000 description 2
- 241001646725 Mycobacterium tuberculosis H37Rv Species 0.000 description 2
- 108700035964 Mycobacterium tuberculosis HsaD Proteins 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 238000010609 cell counting kit-8 assay Methods 0.000 description 2
- 230000004663 cell proliferation Effects 0.000 description 2
- 239000006285 cell suspension Substances 0.000 description 2
- 238000002512 chemotherapy Methods 0.000 description 2
- 238000011217 control strategy Methods 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 238000003859 hyphenated technique Methods 0.000 description 2
- 230000003053 immunization Effects 0.000 description 2
- 238000002649 immunization Methods 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 239000007791 liquid phase Substances 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000013642 negative control Substances 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 125000003088 (fluoren-9-ylmethoxy)carbonyl group Chemical group 0.000 description 1
- FRXSZNDVFUDTIR-UHFFFAOYSA-N 6-methoxy-1,2,3,4-tetrahydroquinoline Chemical compound N1CCCC2=CC(OC)=CC=C21 FRXSZNDVFUDTIR-UHFFFAOYSA-N 0.000 description 1
- 208000030507 AIDS Diseases 0.000 description 1
- 101100507655 Canis lupus familiaris HSPA1 gene Proteins 0.000 description 1
- 241001232809 Chorista Species 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 206010013453 Disseminated tuberculosis Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 101000914514 Homo sapiens T-cell-specific surface glycoprotein CD28 Proteins 0.000 description 1
- 201000006836 Miliary Tuberculosis Diseases 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 102100027213 T-cell-specific surface glycoprotein CD28 Human genes 0.000 description 1
- GLNADSQYFUSGOU-GPTZEZBUSA-J Trypan blue Chemical compound [Na+].[Na+].[Na+].[Na+].C1=C(S([O-])(=O)=O)C=C2C=C(S([O-])(=O)=O)C(/N=N/C3=CC=C(C=C3C)C=3C=C(C(=CC=3)\N=N\C=3C(=CC4=CC(=CC(N)=C4C=3O)S([O-])(=O)=O)S([O-])(=O)=O)C)=C(O)C2=C1N GLNADSQYFUSGOU-GPTZEZBUSA-J 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 238000005299 abrasion Methods 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 208000036984 extensively drug-resistant tuberculosis Diseases 0.000 description 1
- 208000002672 hepatitis B Diseases 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 238000001819 mass spectrum Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 201000009671 multidrug-resistant tuberculosis Diseases 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000000700 radioactive tracer Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 229960002109 tuberculosis vaccine Drugs 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Images
Landscapes
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Description
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2012101150863A CN102653554B (zh) | 2011-04-22 | 2012-04-18 | 功能性结核分枝杆菌抗原多肽及其应用 |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201110101651 | 2011-04-22 | ||
CN201110101651.6 | 2011-04-22 | ||
CN2012101150863A CN102653554B (zh) | 2011-04-22 | 2012-04-18 | 功能性结核分枝杆菌抗原多肽及其应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102653554A true CN102653554A (zh) | 2012-09-05 |
CN102653554B CN102653554B (zh) | 2013-12-04 |
Family
ID=46729299
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2012101148613A Expired - Fee Related CN102675425B (zh) | 2011-04-22 | 2012-04-18 | 一种功能性结核分枝杆菌抗原多肽及其应用 |
CN2012101150863A Expired - Fee Related CN102653554B (zh) | 2011-04-22 | 2012-04-18 | 功能性结核分枝杆菌抗原多肽及其应用 |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2012101148613A Expired - Fee Related CN102675425B (zh) | 2011-04-22 | 2012-04-18 | 一种功能性结核分枝杆菌抗原多肽及其应用 |
Country Status (1)
Country | Link |
---|---|
CN (2) | CN102675425B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103304636A (zh) * | 2012-03-09 | 2013-09-18 | 中国医学科学院病原生物学研究所 | 一种结核分枝杆菌候选抗原多肽及其应用 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101289496A (zh) * | 2008-05-30 | 2008-10-22 | 中国医学科学院医学生物学研究所 | 能激发机体抗结核杆菌的保护性免疫反应的抗原表位筛选方法及用途 |
CN101367867A (zh) * | 2007-08-14 | 2009-02-18 | 深圳市达科为生物技术有限公司 | 特异性检测结核杆菌感染的多肽、方法及试剂盒 |
CN101446585A (zh) * | 2008-12-29 | 2009-06-03 | 中山大学 | 一种体外检测结核杆菌感染的试剂和方法 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA200400843B (en) * | 2001-08-02 | 2007-11-28 | Univ New York | Early detection of mycobacterial disease using peptides |
WO2007005627A2 (en) * | 2005-07-01 | 2007-01-11 | Forsyth Dental Infirmary For Children | Tuberculosis antigen detection assays and vaccines |
CN100415771C (zh) * | 2006-06-06 | 2008-09-03 | 中国人民解放军第二军医大学 | 激发人体抗结核杆菌的保护性免疫反应的抗原表位及其用途 |
CN101298471B (zh) * | 2006-06-06 | 2011-01-19 | 中国人民解放军第二军医大学 | 激发人体抗结核杆菌的保护性免疫反应的抗原表位及其用途 |
CN101311189B (zh) * | 2006-06-06 | 2010-09-08 | 中国人民解放军第二军医大学 | 激发人体抗结核杆菌的保护性免疫反应的抗原表位及其用途 |
CN101555630A (zh) * | 2009-03-30 | 2009-10-14 | 吉林农业大学 | 结核分枝杆菌噬菌体随机肽库 |
CN102004155B (zh) * | 2010-02-12 | 2013-09-18 | 复旦大学附属华山医院 | 一种检测结核分枝杆菌感染的试剂、方法及应用 |
-
2012
- 2012-04-18 CN CN2012101148613A patent/CN102675425B/zh not_active Expired - Fee Related
- 2012-04-18 CN CN2012101150863A patent/CN102653554B/zh not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101367867A (zh) * | 2007-08-14 | 2009-02-18 | 深圳市达科为生物技术有限公司 | 特异性检测结核杆菌感染的多肽、方法及试剂盒 |
CN101289496A (zh) * | 2008-05-30 | 2008-10-22 | 中国医学科学院医学生物学研究所 | 能激发机体抗结核杆菌的保护性免疫反应的抗原表位筛选方法及用途 |
CN101446585A (zh) * | 2008-12-29 | 2009-06-03 | 中山大学 | 一种体外检测结核杆菌感染的试剂和方法 |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103304636A (zh) * | 2012-03-09 | 2013-09-18 | 中国医学科学院病原生物学研究所 | 一种结核分枝杆菌候选抗原多肽及其应用 |
CN103304636B (zh) * | 2012-03-09 | 2014-12-10 | 中国医学科学院病原生物学研究所 | 一种结核分枝杆菌候选抗原多肽及其应用 |
Also Published As
Publication number | Publication date |
---|---|
CN102653554B (zh) | 2013-12-04 |
CN102675425A (zh) | 2012-09-19 |
CN102675425B (zh) | 2013-12-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Parham | The immune system | |
Brent | A history of transplantation immunology | |
Mestecky et al. | Mucosal immunology | |
Mitchell et al. | Transmissible agents from human sarcoid and Crohn's disease tissues | |
CN103550244B (zh) | 一种具有协同增强体液和细胞免疫作用的中药复合多糖及应用 | |
CN103266119B (zh) | 一种结核杆菌三抗原融合基因疫苗及其制备方法和应用 | |
Clark | At war within: The double-edged sword of immunity | |
CN102847144B (zh) | 一种提高机体免疫功能的细胞类生物药物、及其制备方法和应用 | |
WO1999027948A2 (en) | Use of soluble recombinant human cd40l protein for inhibiting in vivo immune response | |
CN104098700A (zh) | 结核分枝杆菌融合蛋白eammh、其构建、表达和纯化方法及其应用 | |
Rao | Immunology: A textbook | |
CN102653554B (zh) | 功能性结核分枝杆菌抗原多肽及其应用 | |
Denisov et al. | Immunopotentiation of live brucellosis vaccine by adjuvants | |
Leong | Molecular and biotechnological approaches to fish vaccines | |
Byrom et al. | CD8+ T cell knockout mice are less susceptible to Cowdria ruminantium infection than athymic, CD4+ T cell knockout, and normal C57BL/6 mice | |
CN101934073B (zh) | 牛病毒性腹泻病毒转基因黄芪疫苗及生产方法 | |
CN100443502C (zh) | 一种防治对虾病毒病的卵黄免疫球蛋白及其制备方法和应用 | |
Rao | An introduction to immunology | |
Ling et al. | A new approach to controlling ichthyophthiriasis in a closed culture system of freshwater ornamental fish. | |
CN101314032B (zh) | 伤寒、副伤寒特异性转移因子口服制剂的制备工艺 | |
Byrom et al. | A polarized Th1 type immune response to Cowdria ruminantium infection is detected in immune DBA/2 mice | |
CN107267430A (zh) | 布鲁氏菌104M疫苗株敲除Omp25基因的重组菌及应用 | |
Perera | At the Edge of Mysteries: The Discovery of the Immune System | |
Basir | Textbook of immunology | |
Fryer | Development of bacterins and vaccines for control of infectious diseases in fish |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C53 | Correction of patent of invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Yu Yang Inventor after: Liu Haiying Inventor after: Zhang Yan Inventor after: Jin Qi Inventor after: Chen Xinchun Inventor before: Yu Yang Inventor before: Liu Haiying Inventor before: Zhang Yan Inventor before: Jin Qi |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: YU YANG LIU HAIYING ZHANG YAN JIN QI TO: YU YANG LIU HAIYING ZHANG YAN JINQI CHEN XINCHUN |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20131204 |